MedPath

Management of Covid-19 Patients During Home Isolation

Not Applicable
Conditions
Covid 19
Registration Number
NCT04368923
Lead Sponsor
Cairo University
Brief Summary

This study will be concerned with managing patients of Covid-19 while being home isolated.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Patients with Covid-19
  • American Society of Anesthesiologists (ASA) class I
  • >= 21 years old
  • <= 40 years old
Exclusion Criteria
  • ASA class II, class III or class IV

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Arterial Blood Gases (ABG): Partial Pressure of Oxygen and Carbon Dioxide48 hours
Arterial Blood Gases (ABG): Acidity Potential Hydrogen (pH)48 hours
Secondary Outcome Measures
NameTimeMethod
Vital Signs (Temprature)24 hours
Vital Signs (Blood Pressure)24 hours
Vital Signs (Oxygen Saturation)24 hours
Vital Signs (Respiratory Rate)24 hours
Vital Signs (Heart Rate)24 hours

Trial Locations

Locations (1)

M. Sedky

🇪🇬

Cairo, Egypt

M. Sedky
🇪🇬Cairo, Egypt

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.